Evaluating the role of non-alcoholic fatty liver disease in cardiovascular diseases and type 2 diabetes: a Mendelian randomization study in Europeans and East Asians
- 11 November 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 52 (3) , 921-931
Abstract
Background: Whether non-alcoholic fatty liver disease (NAFLD) causes cardiovascular disease (CVD) and type 2 diabetes (T2D) is unclear and possible differences between ethnicities have not been thoroughly explored. We used Mendelian randomization (MR) to assess the role of NAFLD in CVD and T2D risk in Europeans and East Asians. Methods: We conducted a MR study using genetic predictors of alanine aminotransferase (ALT), liability to NAFLD, aspartate transaminase (AST), liver magnetic resonance imaging corrected T1 and proton density fat fraction and combined them with genome-wide association studies (GWAS) summary statistics of CVD, T2D and glycaemic traits (sample size ranging from 14 400 to 977 320). Inverse-variance weighted analysis was used to assess the effect of NAFLD in these outcomes, with sensitivity analyses and replication in FinnGen. We conducted analyses in East Asians using ethnicity-specific genetic predictors of ALT and AST, and the respective outcome GWAS summary statistics. Results: In Europeans, higher ALT was associated with higher T2D risk (odds ratio: 1.77 per standard deviation, 95% CI 1.5 to 2.08), with similar results for other exposures, across sensitivity analyses and in FinnGen. Although NAFLD proxies were related to higher coronary artery disease (CAD) and stroke risk, sensitivity analyses suggested possible bias by horizontal pleiotropy. In East Asians, higher ALT was possibly associated with higher T2D risk, and ALT and AST were inversely associated with CAD. Conclusions: NAFLD likely increases the risk of T2D in Europeans and East Asians. Potential differential effects on CAD between Europeans and East Asians require further investigation.Keywords
Funding Information
- Li Ka Shing Faculty of Medicine
- The University of Hong Kong
- Medical Research Council
- Skills Development Fellowship (MR/P014054/1)
- British Heart Foundation (AA/18/7/34219, CH/F/20/90003)
- University of Bristol (MC_UU_00011/6)
This publication has 54 references indexed in Scilit:
- Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regressionInternational Journal of Epidemiology, 2015
- Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndromeThe Lancet Diabetes & Endocrinology, 2014
- Liver enzymes and risk of cardiovascular disease in the general population: A meta-analysis of prospective cohort studiesAtherosclerosis, 2014
- Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder PopulationPLOS Genetics, 2014
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2014
- Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitroJournal of Hepatology, 2012
- Alanine transaminase has opposite associations with death from diabetes and ischemic heart disease in NHANES IIIAnnals of Epidemiology, 2012
- The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomesInternational Journal of Epidemiology, 2011
- Liver Enzymes, Nonalcoholic Fatty Liver Disease, and Incident Cardiovascular Disease: A Narrative Review and Clinical Perspective of Prospective Data†Hepatology, 2010
- Alanine Aminotransferase, γ-Glutamyltransferase, and Incident DiabetesDiabetes Care, 2009